Pancreatic Cancer Research

ResearcherUniversity of Nebraska Medical CenterNo recent work listed

Dhanya Haridas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6146-6168; OpenAlex author ID A5008413709. Sources: OpenAlex.

Their work

Papers
12 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2011: 1 paper · 2012: 2 papers · 2013: 1 paper · 2014: none · 2015: 5 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 1 paper

Papers 12

  1. Muc16 depletion diminishes KRAS-induced tumorigenesis and metastasis by altering tumor microenvironment factors in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41388-022-02493-6↗
  2. Acinar transformed ductal cells exhibit differential mucin expression in a tamoxifen-induced pancreatic ductal adenocarcinoma mouse model. First author DOI 10.1242/bio.052878↗
  3. MUC16 contributes to the metastasis of pancreatic ductal adenocarcinoma through focal adhesion mediated signaling mechanism. First author DOI 10.18632/genesandcancer.104↗
  4. Clinical implications of miRNAs in the pathogenesis, diagnosis and therapy of pancreatic cancer. Co-author DOI 10.1016/j.addr.2014.10.020↗
  5. Amyloid precursor-like protein 2 (APLP2) affects the actin cytoskeleton and increases pancreatic cancer growth and metastasis. Co-author DOI 10.18632/oncotarget.2990↗
  6. Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancer. Co-author DOI 10.18632/oncotarget.3286↗
  7. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. Co-author DOI 10.18632/oncotarget.3912↗
  8. MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. Co-author DOI 10.18632/oncotarget.4078↗
  9. Immunocytochemistry for MUC4 and MUC16 is a useful adjunct in the diagnosis of pancreatic adenocarcinoma on fine-needle aspiration cytology. Co-author DOI 10.5858/arpa.2011-0229-oa↗
  10. MUC4 potentiates invasion and metastasis of pancreatic cancer cells through stabilization of fibroblast growth factor receptor 1. Co-author DOI 10.1093/carcin/bgs225↗
  11. Mucin (Muc) expression during pancreatic cancer progression in spontaneous mouse model: potential implications for diagnosis and therapy. Co-author DOI 10.1186/1756-8722-5-68↗
  12. Pathobiological implications of MUC16 expression in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0026839↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Surinder K. Batra · 12 shared papers, 2011–2022 · strength 0.64
  2. Satyanarayana Rachagani · 10 shared papers, 2011–2022 · strength 0.55
  3. Parthasarathy Seshacharyulu · 8 shared papers, 2012–2022 · strength 0.50
  4. Moorthy Palanimuthu Ponnusamy · 7 shared papers, 2011–2022 · strength 0.35
  5. Imayavaramban Lakshmanan · 5 shared papers, 2011–2022 · strength 0.29
  6. Sakthivel Muniyan · 3 shared papers, 2016–2022 · strength 0.28
  7. Kavita B. Mallya · 2 shared papers, 2020–2022 · strength 0.22
  8. Maneesh Jain · 4 shared papers, 2012–2022 · strength 0.22
  9. Apar Kishor Ganti · 3 shared papers, 2015–2022 · strength 0.21
  10. Lynette M. Smith · 2 shared papers, 2016–2022 · strength 0.17
  11. Sushil Kumar K · 3 shared papers, 2011–2022 · strength 0.16
  12. Muzafar Ahmad Macha · 3 shared papers, 2012–2015 · strength 0.12
  13. Seema Chugh · 2 shared papers, 2015–2016 · strength 0.11
  14. Sanjib Chaudhary · 1 shared paper, 2022 · strength 0.11
  15. Pranita Atri · 1 shared paper, 2022 · strength 0.11
  16. Sanchita Rauth · 1 shared paper, 2022 · strength 0.11
  17. Seema C. Parte · 1 shared paper, 2022 · strength 0.11
  18. Geoffrey A. Talmon · 1 shared paper, 2022 · strength 0.11
  19. Namita Bhyravbhatla · 1 shared paper, 2022 · strength 0.11
  20. Shailendra Kumar Gautam · 1 shared paper, 2022 · strength 0.11
  21. Ramakanth Chirravuri‐Venkata · 1 shared paper, 2022 · strength 0.11
  22. Ashu Shah · 1 shared paper, 2022 · strength 0.11
  23. Saravanakumar Marimuthu · 1 shared paper, 2022 · strength 0.11
  24. Rama Krishna Nimmakayala · 1 shared paper, 2022 · strength 0.11
  25. Ramesh Pothuraju · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.